MEDICAL TECHNOLOGIES – Pre-commercialization
Artificial intelligence to minimize the risks associated with genetic therapies
AI-GENETIKA helps to make gene editing safer and more predictable in order to accelerate clinical use. It offers a range of patented and specialized tools combining a new CRISPR system and a software platform backed by advanced artificial intelligence. Through machine learning techniques, this platform will help the industry reduce the risk and duration of research and development and be the ideal decision support tool for the choice of rare diseases treatment. genetic.